ST. PAUL, Minn.--(BUSINESS WIRE)--Gallipot, the U.S. leader in creating and supplying compounding products and services for pharmacists, officially has become Fagron. Fagron is the global one-stop shop for products and services for pharmaceutical compounding. It acquired Gallipot in 2010 to build upon Gallipot’s strong U.S. market presence and expand its global reach.
“We changed our name, but kept our brand promise to provide the great service, customer care and innovative, quality compounding products pharmacists have come to rely on from us,” said Gary Schneider, RPh., president, U.S. division of Fagron.
Gallipot served the U.S. pharmacy community since 1979, building a strong reputation on customer-oriented service addressing individual requirements.
As Fagron, the company continues to provide specialized fine bulk chemicals, equipment and supplies to pharmacists. It repackages bulk drugs and manufactures a complete line of topical creams, ointments, gels, lotions and syrups. The company also offers customized state-of-the-art equipment and supplies for pharmacies of every size and type.
In addition, Fagron will be launching a new website, fagron.us, which will provide the added convenience of online shopping and ordering for compounding pharmacists.
Schneider said Gallipot leadership was eager to become part of Fagron to be able to provide U.S. compounding pharmacists with greater, more cost-effective access to innovation, expertise and resources from around the world.
“As Fagron, we have become the leading, resourceful supplier in the United States – even better equipped to help pharmacists meet customer demands and capitalize on new market opportunities,” Schneider said.
Fagron is the global one-stop-shop for products and services for pharmaceutical compounding. It offers high-quality raw materials, compounding bases and vehicles, services and concepts that fulfill the specific and individual wishes of pharmacists and hospitals. Fagron continuously invests in innovation and product development and consequently has a constant, adequate pipeline of new products that will be introduced to the market.